botensilimab,balstilimab
agenus
$agen down 10.87% at $2.09 (volume 18m, avgvolume 5m) in the last 14 min latest news: 7:00 am edt today
agenus shows unprecedented activity for botensilimab/balstilimab combination in microsatellite stable colorectal cancer at esmo world gi congress 
We are excited to officially launch our product! For the first 100 users, you can now get $60 off from the 6-months plan using this code:
coupon code: first100